SET-NUP214 is a recurrent γδ lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALL

Blood

Volumn 123, Issue 12, 2014, Pages 1860-1863

  Abdelali, Raouf Ben ^a,b   Roggy, Anne ^a   Leguay, Thibaut ^c   Cieslak, Agata ^a   Renneville, Aline ^d,e,f   Touzart, Aurore ^a   Banos, Anne ^g   Randriamalala, Edouard ^h   Caillot, Denis ⁱ   Lioure, Bruno ^j   Devidas, Alain ^k   Mossafa, Hossein ^l   Preudhomme, Claude ^d,e,f   Ifrah, Norbert ^m   Dombret, Herve ́ ^a   Macintyre, Elizabeth ^a   Asnafi, Vahid ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c HAUT LÉVÊQUE HOSPITAL   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e UNIV LILLE   (France)

^f JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^g CENTRE HOSPITALIER DE LA CÔTE BASQUE   (France)

^h POITIERS UNIVERSITY HOSPITAL   (France)

ⁱ HÔPITAL DU BOCAGE   (France)

^j HÔPITAL DE HAUTEPIERRE   (France)

^k CH Sud Francilien   (France)

^l LABORATOIRE CERBA   (France)

^m Laboratoire d'Acoustique Environnementale   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGRAFT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; FEMALE; FUSION GENE; GENE EXPRESSION; HUMAN; LEUKEMIA REMISSION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL ACUTE LYMPHOBLASTIC LEUKEMIA; T CELL LEUKEMIA;

ADRENAL CORTEX HORMONES; ADULT; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE REARRANGEMENT, DELTA-CHAIN T-CELL ANTIGEN RECEPTOR; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HISTONE CHAPERONES; HUMANS; MALE; MIDDLE AGED; NUCLEAR PORE COMPLEX PROTEINS; ONCOGENE FUSION; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84897531441     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-08-521518     Document Type: Article

References (25)

1. Huguet F, Leguay T, Raffoux E, et al. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol. 2009;27(6):911-918.
2. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371(9617):1030-1043. (Pubitemid 351389536)
3. Aifantis I, Raetz E, Buonamici S. Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol. 2008;8(5):380-390. (Pubitemid 351595220)
4. Marks DI, Paietta EM, Moorman AV, et al. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). Blood. 2009;114(25):5136-5145.
5. Asnafi V, Radford-Weiss I, Dastugue N, et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. Blood. 2003;102(3):1000-1006. (Pubitemid 36917796)
6. Dik WA, Brahim W, Braun C, et al. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Leukemia. 2005;19(11):1948-1957. (Pubitemid 41554004)
7. Ferrando AA, Armstrong SA, Neuberg DS, et al. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood. 2003;102(1):262-268. (Pubitemid 36759663)
8. von Lindern M, Breems D, van Baal S, Adriaansen H, Grosveld G. Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia. Genes Chromosomes Cancer. 1992;5(3):227-234.
9. Rosati R, La Starza R, Barba G, et al. Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia. Haematologica. 2007;92(2):232-235.
10. Lee SG, Park TS, Cho SY, et al. T-cell acute lymphoblastic leukemia associated with complex karyotype and SET-NUP214 rearrangement: a case study and review of the literature. Ann Clin Lab Sci. 2011;41(3):267-272.
11. Li WJ, Cui L, Gao C, et al. MRD analysis and treatment outcome in three children with SET-NUP214-positive hematological malignancies. Int J Lab Hematol. 2011;33(6):e25-e27.
12. Van Vlierberghe P, van Grotel M, Tchinda J, et al. The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. Blood. 2008;111(9):4668-4680.
13. Chae H, Lim J, Kim M, et al. Phenotypic and genetic characterization of adult T-cell acute lymphoblastic leukemia with del(9)(q34);SET-NUP214 rearrangement. Ann Hematol. 2012;91(2):193-201.
14. Gorello P, La Starza R, Varasano E, et al. Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults. Haematologica. 2010;95(1):79-86.
15. Lee EY, Park TS, Kim MJ, et al. Detection of SET-NUP214 rearrangement using multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) in acute leukemias: a case report and literature review on a Korean case series. Ann Hematol. 2012;91(7):1135-1138.
16. Wang Q, Qiu H, Jiang H, et al. Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia. Haematologica. 2011;96(12):1808-1814.
17. Ben Abdelali R, Asnafi V, Leguay T, et al Group for Research on Adult Acute Lymphoblastic Leukemia. Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study. Blood. 2011;118(19):5099-5107.
18. Kimura N, Akiyoshi T, Uchida T, et al. High prevalence of T cell receptor D delta 2(D delta)J delta rearrangement in CD7-positive early T cell acute lymphoblastic leukemia. Leukemia. 1996;10(4):650-657. (Pubitemid 26144445)
19. Lauzurica P, Krangel MS. Temporal and lineage-specific control of T cell receptor alpha/delta gene rearrangement by T cell receptor alpha and delta enhancers. J Exp Med. 1994;179(6):1913-1921. (Pubitemid 24155672)
20. Coustan-Smith E, Mullighan CG, Onciu M, et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009;10(2):147-156.
21. Ben Abdelali R, Asnafi V, Petit A, et al. The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest. Haematologica. 2013;98(11):1711-1717.
22. Zuurbier L, Gutierrez A, Mullighan CG, et al. Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors. Haematologica. 2014;99(1):94-102.
23. Gupta V, Richards S, Rowe J; Acute Leukemia Stem Cell Transplantation Trialists' Collaborative Group. Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis. Blood. 2013;121(2):339-350.
24. Inukai T, Kiyokawa N, Campana D, et al. Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children's Cancer Study Group Study L99-15. Br J Haematol. 2012;156(3):358-365.
25. Neumann M, Coskun E, Fransecky L, et al. FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors. PLoS ONE. 2013;8(1):e53190.